A phase II Study of OSI-774 in unresectable hepatocellular carcinoma.

被引：0
|
作者：
Thomas, MB
Faria, S
Tamm, E
Rashid, A
Charnsangavej, C
Dancey, J
Abbruzzese, J
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] NCI, Bethesda, MD 20892 USA
来源：
CLINICAL CANCER RESEARCH | 2003年 / 9卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6092S / 6092S
页数：1
相关论文
共 50 条
  • [1] A phase II open-label study of OSI-774 (NSC 718781) in unresectable hepatocellular carcinoma.
    Thomas, MB
    Dutta, A
    Brown, T
    Charnsangavej, C
    Rashid, A
    Hoff, PM
    Dancey, J
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 317S - 317S
  • [2] Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer
    Philip, PA
    Mahoney, MR
    Allmer, C
    Thomas, J
    Pitot, HC
    Kim, G
    Donehower, RC
    Fitch, T
    Picus, J
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (27) : 6657 - 6663
  • [3] OSI-774 in advanced Esophageal Cancer: A phase II study.
    Radovich, D
    Kelsen, D
    Shah, M
    Klimstra, D
    Gavin, SG
    Munoz, D
    Ilson, DH
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 332S - 332S
  • [4] Phase II study of OSI-774 in patients with metastatic colorectal cancer
    Townsley, C
    Major, P
    Siu, LL
    Dancey, J
    Vincent, M
    Pond, G
    MacLean, M
    Moore, MJ
    Oza, AM
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S57 - S57
  • [5] Phase II trial of erlotinib (OSI-774) in patients with hepatocellular or biliary cancer.
    Philip, PA
    Mahoney, M
    Thomas, J
    Pitot, H
    Donehower, R
    Kim, G
    Picus, J
    Fitch, T
    Geyer, S
    Erlichman, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 319S - 319S
  • [6] Phase I and II study of OSI-774 and docetaxel in squamous cell carcinoma of the head and neck (SCCHN).
    Rhoades, CA
    Kraut, E
    Schuller, D
    Zhang, Y
    Chan, K
    Lang, K
    Eng, C
    Grever, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 498S - 498S
  • [7] Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
    C A Townsley
    P Major
    L L Siu
    J Dancey
    E Chen
    G R Pond
    T Nicklee
    J Ho
    D Hedley
    M Tsao
    M J Moore
    A M Oza
    British Journal of Cancer, 2006, 94 : 1136 - 1143
  • [8] Phase I and II study of OSI-774 and docetaxel in squamous cell carcinoma of the head and neck (SSCHN)
    Rhoades, C
    Kraut, E
    Schuller, D
    Chan, K
    Lang, K
    Eng, C
    Grever, M
    Richard, J
    LUNG CANCER, 2004, 46 : S79 - S79
  • [9] Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
    Townsley, CA
    Major, P
    Siu, LL
    Dancey, J
    Chen, E
    Pond, GR
    Nicklee, T
    Ho, J
    Hedley, D
    Tsao, M
    Moore, MJ
    Oza, AM
    BRITISH JOURNAL OF CANCER, 2006, 94 (08) : 1136 - 1143
  • [10] Determinants of response to Erlotinib (OSI-774) in head and neck squamous cell carcinoma.
    Oppenheimer, D
    Amador, ML
    Embuscando, EL
    Iacabuzzio-Douanne, C
    Hidalgo, M
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6090S - 6090S
12345